InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Monksdream PremiumMember
05/04/24 12:27 PM
profile icon
Monksdream PremiumMember
03/26/24 12:28 PM
profile icon
Awl416 Free
05/17/23 9:16 AM
profile icon
ThatHawaiiGuy Grandfathered
09/09/20 6:04 AM
profile icon
erostratus Free
08/24/20 5:24 PM
profile icon
starkd748 Free
08/23/20 4:12 PM
profile icon
Jama87 Free
08/17/20 8:29 AM
profile icon
starkd748 Free
04/30/20 2:41 PM
profile icon
starkd748 Free
04/29/20 6:14 PM
profile icon
starkd748 Free
04/29/20 2:28 PM
profile icon
starkd748 Free
04/29/20 11:42 AM
profile icon
starkd748 Free
04/27/20 2:57 PM
profile icon
starkd748 Free
04/19/20 1:34 PM
profile icon
tomj1 Free
04/19/20 11:48 AM
profile icon
starkd748 Free
04/19/20 10:48 AM
profile icon
tomj1 Free
04/19/20 10:44 AM
profile icon
stock1ace1 Free
03/10/20 2:29 PM
profile icon
hayward Free
02/14/20 1:47 PM
profile icon
ClayTrader Free
12/09/19 5:25 PM
profile icon
wesley_ Free
12/19/18 3:26 PM
profile icon
james_west_1965 Free
06/23/17 7:05 AM

XBiotech, Inc. (XBIT) RSS Feed

Followers
9
Posters
30
Posts (Today)
0
Posts (Total)
76
Created
09/13/15
Type
Free
Moderators
XBiotech, Inc. 8201 East Riverside Drive Suite 100 Austin, TX 78744 United States Phone: 512-386-2900 Fax: 512-386-5505 Website: http://www.xbiotech.com XBiotech, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing ‘True Human’ monoclonal antibodies for treating various different diseases. Its lead product is Xilonix, a novel anti-cancer agent, which has completed enrollment of its pivotal, randomized double-blinded placebo controlled Phase III study in Europe for the treatment of advanced colorectal cancer. Xilonix targets and neutralizes interleukin-1 alpha (IL-1a), a molecule known to promote angiogenesis, growth, and spread of tumors, as well as mediate symptoms, such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company also develops a proprietary True Human monoclonal antibody discovery platform and manufacturing system. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Volume:
Day Range: